B. Braun recalls seven lots of heparin

B. Braun Medical announced a voluntary recall of seven lots of heparin injection after it was notified by its supplier, Scientific Protein Laboratories, that additional testing indicated a trace amount of oversulfated chondroitin sulfate contaminant. These lots were manufactured in 2008 and will be expiring on October 31, 2010 and November 30, 2010. Based on current information, the recalled lots do not pose a significant health risk; however, B. Braun is performing this voluntary recall as a precautionary measure with the support of the FDA.

The following lots are being recalled:
  • 25,000 Units Heparin in 5% Dextrose Injection, 50Units/mL: Lot# J8D674, J8E462
  • 1,000 Units Heparin in 0.9% Sodium Chloride Injection, 2Units/mL: Lot# J8D676, J8D677, J8D702, J8D703, J8E539

Healthcare professionals and patients who have this product in their possession should stop using it immediately.

For more information call (800) 227-2862 or visit www.bbraunusa.com.